An ancient, fundamental cooling technique gets a new, more-efficient implementation via an innovative fiber matrix.
Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback